Dnaaf2 | dynein, axonemal assembly factor 2
Physiological systems
19 / 24 physiological systems tested
3 Significantly impacted by the knock-out
Homeostasis/metabolism Behavior/neurological Mortality/aging
16 No significant impact
5 Not tested
Data collections
Gene metrics:5Significant phenotypes
2Associated diseases
Expression examined in:48Adult tissues
25Embryo tissues
increased circulating sodium level | 1 supporting dataset | Dnaaf2tm1.1(KOMP)Vlcg | heterozygote | Early adult | 6.26x10-9 | ||
increased circulating total protein level | 1 supporting dataset | Dnaaf2tm1.1(KOMP)Vlcg | heterozygote | Early adult | 5.8x10-6 | ||
preweaning lethality, complete penetrance | 1 supporting dataset | Dnaaf2tm1.1(KOMP)Vlcg | homozygote | Early adult | N/A * | ||
embryonic lethality prior to organogenesis | 1 supporting dataset | Dnaaf2tm1.1(KOMP)Vlcg | homozygote | E9.5 | N/A * | ||
abnormal sleep behavior | 1 supporting dataset | Dnaaf2tm1.1(KOMP)Vlcg | heterozygote | Early adult | 8.83x10-5 |
| | | | | | | | | |
External links
No external links available for Dnaaf2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.